Jan T Harding

Jan T Harding supports the Naval Medical Logistics Command in executing critical medical procurement operations essential to sustaining U.S. Navy and Marine Corps combat readiness. Though formal title information is not available, their role centers on managing acquisitions of advanced diagnostic, laboratory, and point-of-care medical systems that directly enable clinical response in deployed and garrisoned environments. Harding handles complex solicitations under FAR Part 13 and Part 15, focusing on high-technology medical equipment requiring rigorous performance validation and supply chain resilience. Their work ensures that frontline medical units receive reliable, FDA-cleared, and MIL-SPEC-compliant instruments critical to casualty care and preventive medicine missions. Harding’s contracting patterns reflect a preference for established commercial suppliers with proven track records in medical device manufacturing and analytical instrumentation. While specific contractor names are not publicly identifiable in available records, their procurement strategy consistently engages Tier 1 medical technology vendors and specialized OEMs capable of meeting stringent DoD quality and traceability standards. Vendor partnerships are typically performance-based, emphasizing technical compliance, lifecycle support, and rapid delivery timelines across global operational theaters. Set-aside preferences indicate a strong emphasis on open competition, with 96.7% of acquisitions conducted without socioeconomic set-asides. The remaining 3.3% are awarded under Total Small Business Set-Asides (FAR 19.5), reflecting a measured but deliberate commitment to small business participation where market capabilities align with mission needs. This approach prioritizes capability over socioeconomic designation, ensuring mission-critical medical systems are procured without compromising performance or availability. Harding’s procurement focus is concentrated in high-precision medical manufacturing sectors, particularly NAICS 811219 (Medical and Diagnostic Laboratory Services), 325413 (In-Vitro Diagnostic Substance Manufacturing), and 339115 (Ophthalmic Goods Manufacturing). They routinely acquire laboratory analyzers, diagnostic reagents, portable imaging devices, and specialized computer storage systems for clinical data management. Their technical expertise lies in the integration of FDA-regulated medical devices with military health information systems, ensuring interoperability and operational reliability under austere conditions.